Cambridge, Massachusetts — March 25, 2014 — /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, today announced that CEO and Co-founder Dr. David Berry will present a company overview at the 21st annual BioCentury Future Leaders in the Biotech Industry Conference.
Dr. Berry's presentation will focus on Seres' development of the first therapeutics that can catalyze a shift to health by augmenting the biology of the microbiome for the treatment of infectious, metabolic, and inflammatory diseases.
The presentation will take place on Friday, March 28, 2014 at 3:50 p.m. ET in presentation room 508 at the Millennium Broadway Hotel in New York City.
For more information on Seres Health please visit www.sereshealth.com
About Seres Health
Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases. For more information, please visit www.sereshealth.com.
For Seres Health